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stantial fraction of this patient population. In this study we
summarize our experience with explantation of the stent-
grafts.
METHODS
Patients. Between September 1994 and December
1998, 150 patients with AAA (mean age, 69.6 ± 8.49
years; 142 men, 8 women) were treated with endoluminal
placement of polyester-covered nitinol stents. We
implanted Stentor stent-grafts (Mialhe Stentor, Min Tec,
Freeport, Bahamas) in 55 patients (5 tube and 50 bifur-
cated). The remaining 95 patients received implantations
of Vanguard devices (Boston Scientific, Oakland, NJ) (3
tube and 92 bifurcated). The demographic data of the 150
patients receiving stent implantations are presented in
Table I. Fourteen (9.3%) of the 150 patients were classi-
fied as class 4 according to the American Society of
Anesthesia physical status. All patients included in the
study had asymptomatic aneurysms. At least 1 week before
the procedure, a spiral computer tomography (CT) and a
multiplane angiography of the abdominal aorta were per-
formed in all patients considered for stent-graft implanta-
tion. Patients with inflammatory abdominal aneurysms, 
as revealed with CT, clinical investigations, and inflamma-
tory parameters, did not receive stent implantations.
Aneurysms were classified as type A (n = 8, involvement of
the abdominal aorta only) or type B or C (n = 142,
Endoluminal stent-graft placement has become an
alternative therapy for the treatment of infrarenal abdom-
inal aortic aneurysms (AAAs) in a number of medical cen-
ters. In these centers only those patients in whom
stent-graft implantation is not possible are referred for
conventional surgery. The change in therapeutic guide-
lines has occurred for the following three reasons: (1)
endoluminal treatment is less invasive than conventional
open surgery1-4; (2) stent-grafts can be deployed with
patients under local anesthesia, thereby offering a less risky
treatment option in high-risk patients5; and (3) stent
implantation has thus far been shown to yield excellent
immediate results after implantation.6-9 However, results
on long-term follow-up are not yet available.
We started to implant stents 5 years ago, and we have
recently encountered an increase of serious complications
that require surgical explantation and replacement of the
stent-graft with a polyester fiber (Dacron) graft in a sub-
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Background: Endoluminal stent-graft placement for the treatment of infrarenal abdominal aortic aneurysms has gained
widespread acceptance because it is associated with lower peri-interventional morbidity than conventional transab-
dominal surgery. In this study the long-term morbidity of the procedure was evaluated.
Methods and Results: Between September 1994 and December 1998, 150 patients (age, 69.6 ± 8.49 years; 142 men, 8
women) with abdominal aortic aneurysms were treated with the placement of an intravascular nitinol stent-graft
(Stentor [55] and Vanguard-System [95]); there were eight tubular grafts and 142 bifurcated grafts. Initial placement
of the stent-graft was successful in 144 patients. Mean follow-up was 49 ± 25 months. In 13.3% of stent-graft place-
ments we encountered the following complications: 4 cases of migration or dislocation of the prosthesis (30.5 ± 7.4
months after placement); 2 ruptures of the aorta (26.7 and 15.0 months after placement); 3 recurrent thromboses of
the stent-graft (25.5 ± 5.3 months after placement); 3 endoleaks (27.5 ± 15.7 months after placement); and 5 infec-
tions of the prosthesis (26.6 ± 16.5 months after placement). There was no correlation between the complications and
the type of stent used. All of these patients were treated by surgical replacement of the prosthesis with a Dacron graft.
Conclusions: (1) The results suggest that most complications are due to a continuation of the disease process leading to
loosening of the prosthesis. (2) Explantation of the prosthesis and surgical repair is feasible but bears additional risks.
(3) Because the onset of reperfusion of the excluded aneurysm cannot be predicted, all patients with infrarenal aortic
stent-grafts require frequent computer tomographic follow-up. (4) Finally, the results call for further improvements in
the design of the stent-graft. (J Vasc Surg 2001;34:198-203.)
involvement of the aortic bifurcation or the bifurcation
and iliac arteries, respectively). Patients with excentric or
saccular aneurysms were excluded from the study. Patient
inclusion criteria for endoluminal treatment of AAA have
been described in detail before6-8 and were as follows: (1)
minimal diameter of aortic aneurysm greater than 50 mm
and (2) proximal aortic neck not less than 10 mm in
length and not more than 27 mm in diameter.
All stent-graft implantations were performed on an
elective basis. The procedures were performed with 121
patients (80.7%) under general anesthesia. Twenty-nine
interventions (19.3%) were performed with patients under
local anesthesia (10-20 mL of 1% lidocaine injected at the
groin cut-down) and sedation (remifentanil 0.05 µg/kg
per minute and midazolam 0.5-1.0 mg, given intra-
venously). All stents were implanted by the same inter-
ventional radiologist assisted by vascular surgeons who
performed the arterial access. All stent-graft implantations
were done in the angiographic suite with the patient pre-
pared as for a conventional, transabdominal procedure.
Before the intervention all patients received a single dose
of broad spectrum antibiotics (cephalosporin; 2 g, given
intravenously) and an additional dose 8 hours thereafter.
Follow-up with CT was scheduled at 1, 6, and 12 months
after implantation and each year thereafter.
Description of the devices. The Min Tec Stentor
graft and the Vanguard device are flexible, self-expanding
endoprostheses that are made from nitinol wire stent
frames covered with a polyester fabric. The Min Tec
Stentor graft has been superseded, has been redesigned,
and has evolved into the Vanguard device. Additionally,
the introducer system for delivery of the stent-grafts has
been modified. Before the Vanguard prosthesis could
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undergo further technical modifications, its realization
was stopped at the end of 1999 after leaks of the prosthe-
sis with subsequent rupture of the aneurysmal sac had
been reported. The stent-grafts, as used in the current
study, were available in straight or bifurcated designs and
selected according to the anatomy of the aneurysms. The
devices were commercially available in standard sizes and
were selected individually for each patient.10 Both devices
have been extensively described before.6-8
Introduction of the devices. The introduction and
deployment of the devices have been described in detail
elsewhere.6-8 Briefly, after induction of anesthesia, heparin
(100 IU/kg) was given. The femoral arteries were
exposed by a standard groin incision on the left or right
side, and the aortic section, plus the ipsilateral iliac limb of
the stent prosthesis, was implanted under fluoroscopic
guidance with the introduction catheter. If a bifurcated
graft was needed, contralateral percutaneous femoral
puncture was performed, and the introducer containing
the second limb of the stent-graft was inserted. After
exclusion of the AAA, the arteriotomy and the groin inci-
sion were closed.
If the procedure was performed with patients under
general anesthesia, the patients were intubated and trans-
ferred to the intensive care unit. After routine extubation,
the patients were observed while in the intensive care unit
for 12 hours before they were transferred to the ward. If
the procedure was performed with patients under local
anesthesia, patients were transferred immediately after the
intervention to the ward.
All patients received heparin intravenously for 48
Fig 1. Outcome of 150 patients after endoluminal stent-graft
placement for the treatment of infrarenal aortic aneurysms.
Table I. Characteristics of 150 patients treated with
endoluminal aortic stents (September 1994 to December
1998).
Characteristic Value %
Age (y)
Mean ± SD 69 ± 8.8
Range 49-87
Sex
Male 142 95
Female 8 5
Device
Stentor 55 37
Vanguard 95 63
Type AAA
A 8 5
B/C 142 95
ASA
II 27 18
III 109 73
IV 14 9
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesia
physical status; type A, involvement of the aorta only; type B/C, involve-
ment of the aortic bifurcation or the bifurcation and the iliac arteries,
respectively.
hours after the intervention (partial thromboplastin time,
40-60 seconds) followed by long-term treatment with
aspirin 100 mg/d. 
Explantation of the stent-graft prosthesis. Explan-
tation was indicated for reasons stated below, if additional
stent-graft placement was unsuccessful, or if not possible.
The following was the explanation procedure: After trans-
verse laparotomy and exposure of the aneurysm, the left
renal vein was mobilized, and the aorta was clamped as
proximal as possible but just distally to the renal arteries.
The aneurysm was opened longitudinally, and the stents
were released from the surrounding vascular tissue without
a reopening of the aortic cross-clamp. A dislocated pros-
thesis could be removed from the aneurysmal sac manually
without tractive force. In all other cases, the body of the
stent-graft was grasped with a vascular clamp, and the
anchoring part of the stent was released from its position.
After the stent prosthesis was removed, the iliac arteries
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were blocked with balloon catheters, and a Dacron-
bifurcated graft was placed in conventional manner.11
In all cases a distinct ring formed by the neck of the
aneurysm remained inferior to the renal arteries, which
could be used for the proximal suture line of the Dacron
prosthesis. Pledgets of polytef (Teflon) felt were routinely
incorporated into the proximal suture line. The Dacron
prosthesis was routinely soaked with an antibiotic solution
(rifampin 600 mg) before its implantation in patients with
infected stent-grafts. If the new graft could not be covered
with the remaining aortic wall tissue, the omentum was
used to achieve total coverage. The placement of omen-
tum was especially important in those cases where infec-
tion of the prosthesis required excision of large parts of the
surrounding tissue.
RESULTS
Successful deployment of the stent-grafts was achieved
in 144 patients (96%). In three patients (2%) stent implan-
tation was unsuccessful because of insertion failure of the
introducer delivery system (Stentor [1]; Vanguard [2]). In
another three patients conversion to open procedure had to
be performed immediately because of rupture of the iliac
artery by the introduction system in one patient (Stentor)
and proximal displacement of the endovascular prosthesis
with subsequent refilling of the aneurysm in two patients
(Vanguard). Sixteen patients were lost for further follow-up
studies. The remaining 128 patients were followed up
between 11 and 60 months (mean, 49 ± 25 months) after
initial successful stent-graft placement (Fig 1).
We encountered complications that required explanta-
tion of the stent-graft within the first 4 years in 13.3%
(20/150) of the cases (during the peri-intervention period
[3]; during follow-up period [17]). Table II shows the dif-
ferent complications that require explantation of the stent-
graft during the follow-up period. Stents were found to be
dislocated, with leakage, thrombosed, ruptured, or
infected. Dislocation of the stent-graft with distal displace-
ment of its body in the direction of the blood flow
occurred in four patients (Table II). There was no correla-
tion between the length of the aortic neck and dislocation
of the endoprosthesis (Table II). Contrary to expectations,
in only one of four patients who required explantation of
the graft because of stent dislocation, the length of the aor-
tic neck was shorter than 15 mm at the time of the primary
intervention. Interestingly, widening of the aortic neck was
diagnosed in three of four patients with dislocated stent-
grafts during follow-up (Table II). Additionally, two of
these patients presented with an angulation of the aortic
neck, which hindered a reintervention by deployment of an
endovascular “cuff” between the renal arteries and dis-
placed graft. Fig 2 shows an example of a dislocation of the
stent-graft prosthesis with displacement of its body in the
direction of the blood flow. Leaks requiring explantation of
the stent were detected in three patients (Table II) at 14.0
months since 49.6 months after initially successful exclu-
sion of the aneurysm.
Thrombosis of a limb of the prosthesis occurred in
Fig 2. Arterial subtraction angiography of a 69-year-old patient
with dislocation of infrarenal aortic stent-graft prosthesis 42
months after successful implantation. Arrow is pointing to stent
inside aorta. Stent is dislocated at the proximal neck. See text for
further details.
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three patients (Table II). Two of these patients presented
with recurrent thrombosis despite local and systemic
thrombolytic therapy. In all three patients with thrombo-
sis of the stent, the follow-up aortography of the aorta
detected an acute angulation between the body of the
bifurcated graft and its modular, iliac component.
Despite an implanted stent, rupture of the AAA
occurred in two patients, 26.7 and 15.0 months after stent
implantation (Fig 3, Table II). In both patients a follow-
up CT scan 3 months or 6 weeks before the rupture of 
the AAA did not show any endoleak. However, there 
was an increase in diameter of the aneurysm of 17 mm and
20 mm.
Graft infection that required explantation of the stent
was diagnosed in five patients (Table II). Patients with
infected stent-grafts were admitted between 6.7 and 55.8
months after initial stent-graft placement. In three of the
cases further interventions (thrombolysis, stent) had been
necessary 26.7 ± 23.3 months after initial implantation (ie,
6.7 ± 4.6 months before explantation). All patients pre-
sented with recurrent fever, elevation of C-reactive pep-
tide, leukocytosis, and persistent back or abdominal pain
and were treated with broad spectrum antibiotics intra-
venously as soon as they were admitted to the hospital.
Repeated blood cultures before explantation of the stent-
graft could not recover organisms in any patient. The
diagnosis of graft infection was supported with CT find-
ings, which showed air entrapment around the stent-graft
prosthesis in three patients (Fig 4) and a thickened
aneurysm wall that was in direct contact with an intestinal
loop in two patients. Although the CT findings suggested
the presence of aortoduodenal fistulas, no gastrointestinal
bleeding was encountered in any of the patients. However,
after the adherent intestinal loops were released from the
aneurysm wall, the prosthesis was directly visible in one
patient, which suggested the presence of a lumen con-
necting the aneurysm and the enteral cavity. At operation
a dense, shiny, and highly vascular reaction of the aneurys-
mal sac was diagnosed in all five patients with graft infec-
tion. Cultures of the aortic wall and the surface of the
stent-graft were taken from all patients. One patient, who
presented with a lumen in the aneurysmal wall at the time
of stent-graft explantation, was positive for bacteria cul-
ture (Escherichia coli), suggesting the presence of an
aorto-enteral fistula. The cultures in the remaining
patients were negative for bacteria.
All explantation procedures were performed with
patients under general anesthesia. Explantation of the
stents had to be performed on an emergency basis in three
patients (rupture of AAA [2]; rupture of iliac artery [1]).
In 17 patients the prosthesis was explantated electively. In
all cases a transperitoneal approach was used, and
infrarenal cross-clamping of the aorta was possible. In five
of the 20 patients, we encountered complications during
or after the operation. In one patient the thrombosis of
the graft resulted in limb ischemia. Explantation of the
graft and implantation of a Dacron graft did not rescue the
leg. One patient died of multiorgan failure 6 days after
stent explantation. In one patient acute renal failure devel-
oped perioperatively; in another, a wound infection devel-
Table II. Complications that require explantation of the stent-graft during follow-up
Initial stent-graft implantation Follow-up
Diameter of Time span
Diameter of Maximal proximal neck (mo)
No. of proximal neck of diameter of Type of Configuration of AAAs (mm) Additional implantation-
patients Age (y) AAAs (mm) AAAs (mm) device of device at follow- up Complication findings explantation
1 71 22* 64 Stentor Tube 22 Migration Leakage 27.1
2 55 22† 50 Stentor Y 27 Migration Leakage 30.6
3 69 24† 50 Stentor Y 30 Migration Leakage, tear in Dacron 42.1
4 71 21† 53 Vanguard Y 27 Migration Leakage 22.1
5 70 24 50 Stentor Y — Rupture Increase in diameter of AAA 26.7
6 76 23 58 Stentor Y — Rupture Increase in diameter of AAA 15.0
7 55 22 52 Stentor Y 23 Leakage No dislocation, 49.6
progressive leakage
8 58 27 40 Vanguard Y 28 Leakage No dislocation, 14.0
progressive leakage
9 60 23 60 Vanguard Y 23 Leakage No dislocation, 19.0
additional proximal stent
10 59 22 53 Stentor Y 22 Thrombosis Leakage after thrombolysis 18.1
11 81 21 61 Vanguard Y 22 Thrombosis Multiple lysis 29.0
12 64 22 60 Vanguard Y 22 Thrombosis Leakage after thrombolysis 29.5
13 60 22 59 Stentor Y 27 Infection Air entrapment around stent 30.1
14 76 26 57 Vanguard Y 30 Infection 17.1
15 69 23 54 Vanguard Y 26 Infection Air entrapment around stent 23.3
16 61 22 54 Stentor Y 22 Infection Air entrapment around stent 55.8
17 76 21 47 Vanguard Y 23 Infection 6.7
*Length of proximal neck = 10 mm.
†Length of proximal neck > 15 mm.
AAA, Abdominal aortic aneurysm.
oped. A third patient had respiratory failure and required
temporary support.
DISCUSSION
We demonstrate that stent-graft placement for treat-
ment of AAA is associated with a considerable risk of seri-
ous complications during long-term follow-up. We
encountered serious complications in 13% of the patients
during the first 4 years, which were independent of the
type of the implanted device. The origin of the encoun-
tered complications can be characterized by two pathome-
chanisms: (1) widening of the proximal neck of the aorta
leading to dislocation of the stent-graft with subsequent
thrombosis or leakage and (2) infection associated with
the placement of a foreign body. 
Neck widening and stent dislocation. Dislocation
of the stent-grafts from the proximal fixation site caused
most of the complications that required stent explanta-
tion. Dislocation of the stents led to refilling of the AAA,
which resulted in rupture despite an implanted stent in
two of six patients and caused thrombosis of the stent
because of damage to the nitinol wire frame. The patho-
mechanism of stent dislocation can be characterized either
by progression of the disease process and subsequent
widening of the aortic neck or by failure of the fixation of
the stent-graft prosthesis in the first place. Because the ini-
tial implantation of those stents that had to be explantated
during follow-up was without complications, in our
hands, it is reasonable to conclude that failure of stent fix-
ation is not responsible for the dislocations. However, we
found widening of the aortic neck of about 25% in three
of four patients with dislocations of the stent. There was
no correlation between preinterventional diameter or
length of the aortic neck and the dislocation. Thus, it
appears that a continuation of the disease process may be
responsible for most of the complications encountered
and that the fixation mechanism of the stents is not
designed to prevent this scenario. Although these findings
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are in contrast to a recent study by Walker et al,12 who did
not find any evidence for proximal neck widening and sub-
sequent dislocation after endoluminal repair of AAA in
112 patients during a 4-year period, the presence of fur-
ther neck widening has to be kept in mind because the
consequences can be devastating (as documented by the
patient who died after stent explantation). Our results sug-
gest that widening of the aortic neck is a crucial part in the
pathomechanism of dislocation and must be addressed in
the design of stent-grafts in the future.
Stent implantation and infection. Graft infection
was the second most frequent reason for graft explanta-
tion. Two mechanisms have to be considered for the
occurrence of graft infection. First, the infection may be
related to the implantation procedure,13 especially in
those cases where further interventions were required.
Clearly, every intervention poses a risk for infection by
contamination of the devices used or other nonspecific
mechanisms. Although reinterventions were necessary in
30% of all cases (data not presented), we found no corre-
lation between the time or the number of the interven-
tions and the onset of symptoms. Because of the late onset
of the stent-graft infection, it is likely that the pathomech-
anism of infection of the stent prosthesis is not related to
intraoperative contamination but rather to distant septic
foci or infection from intestinal organisms. The preopera-
tive treatment with broad spectrum antibiotics might
explain that blood cultures were negative for bacteria in
most cases.
The second mechanism may be related to mechanical
irritation of the surrounding tissue by the stent-graft caus-
ing erosion of the aortic wall and the development of an
aorto-enteral fistula.14 Although we did not find any acute
bleeding at the time of operation, we found a hole in the
Fig 3. CT image of the abdomen of a 76-year-old patient with
rupture of an AAA despite an implanted stent-graft. Arrow is
pointing to site of rupture. See text for further details.
Fig 4. CT image of the abdomen of a 69-year-old patient with
graft infection. Arrow is pointing to air inclusion around stent-
graft prosthesis. See text for further details.
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aneurysm after removal of the adhering intestines, suggest-
ing the presence of a lumen. This mechanism would also be
in agreement with the lack of microorganisms in the blood
cultures. Because no bleeding was observed during explan-
tation, one might speculate that the stents were infected
from intestinal organisms through a fistula, and the inflam-
matory reaction of the body preceded the septic compo-
nent of this process. If this mechanism holds true, the
long-term durability of these stents may be rather grim.
Complications associated with or despite the
explantation. Explantation of the devices was easy to per-
form in each of our patients, although we encountered
perioperative complications in 25% of our patients, includ-
ing one death.15 Infrarenal clamping of the aorta was pos-
sible in every patient because all stent-grafts had been
fixated below the renal arteries. Other investigators rec-
ommend suprarenal deployment of the stents to prevent
dislocation.16 If stent-graft explantation becomes neces-
sary in patients with suprarenal fixation, suprarenal clamp-
ing will be necessary during explantation. This procedure
will be associated with ischemia to the kidneys, which
increases the perioperative risk substantially. In our
patients, dislocation was unrelated to the diameter or the
length of the aneurysm neck at the time of implantation.
For these reasons, we advise caution for the liberal use of
suprarenal fixation of aortic stent-grafts.
Limitations of the study. The accuracy of the data
presented may be limited by an incomplete follow-up. It is
most likely that we underestimated rather than overesti-
mated the true number of complications. Although it is
reasonable to conclude that most patients with serious
complications and symptoms that require explantation are
included in the study, it is conceivable that more patients
with stents already require reintervention or explanation.
Because of the symptom-free nature of the disease and the
excellent immediate results of stent implantation, it may
be difficult to improve follow-up compliance of the
patients. However, regular CT scans (every 6-12 months)
appear to be an absolutely necessary component of the 
follow-up process to guarantee patient safety. In addition,
criteria have to be defined when explantation may be indi-
cated, even in the absence of leaks or thrombosis. The two
cases where rupture of the aneurysm occurred shortly after
an uneventful CT scan support this notion.
CONCLUSIONS
We conclude that
1. Stent-graft placement for treatment of AAA is associ-
ated with a considerable risk of serious complications
during long-term follow-up. More complications may
be expected as the time of follow-up increases.
2. Long-term complications have to be considered when
a decision for stent implantation is made.
3. All patients with stent-grafts must be followed up with
CT scan at 6- to 12-month intervals. Regardless of the
presence or absence of an endoleak, any increase in
diameter of the AAA after endoluminal repair might
be a marker of repressurization of the aneurysmal sac,
which requires prompt attention.
4. Explantation criteria have to be defined.
5. The suggested pathomechanisms of the complications
call for an improved design of future stents.
We wish to thank Dr Koppany Sarai for surgical guid-
ance and the many helpful discussions, and Heinrich
Taegtmeyer, MD, DPhil, for valuable suggestions. 
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